I
Ira Pastan
Researcher at Laboratory of Molecular Biology
Publications - 1304
Citations - 113191
Ira Pastan is an academic researcher from Laboratory of Molecular Biology. The author has contributed to research in topics: Immunotoxin & Pseudomonas exotoxin. The author has an hindex of 160, co-authored 1286 publications receiving 110069 citations. Previous affiliations of Ira Pastan include Heidelberg University & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.
TL;DR: It is shown that human embryonic kidney 293T cells that are widely used for transient protein expression can be used for cell surface display of single-chain Fv antibodies for affinity maturation and successfully obtained a highly enriched mutant with increased binding affinity for CD22 after a single selection of a combinatory library randomizing an intrinsic antibody hotspot.
Journal ArticleDOI
Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cells.
TL;DR: The results suggest that those organelles containing transferrin, but not EGF, participate in the return of receptor-bound transferrin to the cell surface.
Journal ArticleDOI
Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine
TL;DR: It is demonstrated that centrally active AChE inhibitors prevent long-lasting behavioral abnormalities associated with cocaine and morphine addictions by potentiating the actions of ACh released from the NAc cholinergic neurons.
Journal ArticleDOI
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers.
Raffit Hassan,Steven J. Cohen,M. Phillips,Ira Pastan,Elad Sharon,Ronan J. Kelly,Charles Schweizer,Susan C. Weil,Daniel A. Laheru +8 more
TL;DR: A phase I clinical trial of MORAb-009 in patients with advanced mesothelin-expressing cancers to determine its safety, dose-limiting toxicity (DLT), and maximum tolerated dose (MTD).
Journal ArticleDOI
Pleiotropic deficiency of carbohydrate utilization in an adenyl cyclase deficient mutant of Escherichia coli.
Robert L. Perlman,Ira Pastan +1 more
TL;DR: It is concluded that cyclic AMP is necessary for the normal utilization of a number of carbon sources by E. coli, because it is required for the synthesis of enzymes involved in their metabolism.